Iron and CYP2E1-dependent oxidative stress and toxicity

被引:56
作者
Cederbaum, AI [1 ]
机构
[1] CUNY Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA
关键词
CYP2E1; iron; ferric complexes; oxidative stress; reactive oxygen production; lipid peroxidation; microsomal electron transfer; alcohol toxicity;
D O I
10.1016/S0741-8329(03)00104-6
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Iron plays a critical role in catalyzing the formation of potent oxidants. Increases in iron content enhance oxidative stress, whereas removal of iron deceases such stress. An association between iron and alcoholic liver injury has been proposed. The ability of iron to modulate the biochemical and toxicologic actions of cytochrome P450 2E1 (CYP2E1) has been evaluated by using isolated microsomes and intact liver cells. The ability of different iron complexes to stimulate microsomal lipid peroxidation and hydroxyl radical production during reduced form of nicotinamide adenine dinucleotide phosphate (NADPH)- and reduced form of nicotinamide adenine dinucleotide (NADH)-dependent electron transfer has been characterized. Certain iron complexes have been shown to be effective in promoting lipid peroxidation; others are better catalysts of hydroxyl radical production as a complex pattern has been found. Reactive oxygen production, lipid peroxidation, and interaction with iron chelates have been shown to be enhanced with microsomes isolated from ethanol-treated rats with elevated levels of CYP2E1. This increase was prevented by anti-CYP2E1 immunoglobulin (Ig)G or chemical inhibitors of CYP2E1. Thus, in the presence of iron complexes, microsomes enriched in CYP2E1 are especially reactive in generation of reactive oxygen species. To assess the toxicologic significance of this iron-CYP2E1 interaction, iron (ferric-nitrilotri acetate) was added to HepG2 cells, which were engineered to express the human CYP2E1. Ferric-nitrilotriacetate produced a greater toxicity in the CYP2E1-expressing HepG2 cells than that in control HepG2 cells. This enhanced, synergistic toxicity was blocked by antioxidants and inhibitors of CYP2E1. Mitochondrial membrane potential and ATP levels were decreased, and damage to the mitochondria played a critical role in the CYP2E1-plus-iron-dependent toxicity. These results support the suggestion that low concentrations of iron and polyunsaturated fatty acids can act as priming or sensitizing factors for CYP2E1-induced injury in HepG2 cells and hepatocytes. Such interactions may play a role in alcohol-induced liver injury. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:115 / 120
页数:6
相关论文
共 47 条
[1]  
AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X
[2]   Iron in liver diseases other than hemochromatosis [J].
Bonkovsky, HL ;
Banner, BF ;
Lambrecht, RW ;
Rubin, RB .
SEMINARS IN LIVER DISEASE, 1996, 16 (01) :65-82
[3]  
Caro AA, 2001, MOL PHARMACOL, V60, P742
[4]   ROLE OF CYTOCHROME-P-450 2E1 IN ETHANOL-DEPENDENT, CARBON TETRACHLORIDE-DEPENDENT AND IRON-DEPENDENT MICROSOMAL LIPID-PEROXIDATION [J].
CASTILLO, T ;
KOOP, DR ;
KAMIMURA, S ;
TRIADAFILOPOULOS, G ;
TSUKAMOTO, H .
HEPATOLOGY, 1992, 16 (04) :992-996
[5]   Introduction - Serial review: Alcohol, oxidative stress and cell injury [J].
Cederbaum, AI .
FREE RADICAL BIOLOGY AND MEDICINE, 2001, 31 (12) :1524-1526
[6]   Cytotoxicity and apoptosis produced by arachidonic acid in hep G2 cells overexpressing human cytochrome P4502E1 [J].
Chen, Q ;
Galleano, M ;
Cederbaum, AI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) :14532-14541
[7]   Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in Hep G2 cells [J].
Chen, Q ;
Cederbaum, AI .
MOLECULAR PHARMACOLOGY, 1998, 53 (04) :638-648
[8]   SYNERGISTIC INTERACTIONS BETWEEN NADPH CYTOCHROME-P-450 REDUCTASE, PARAQUAT, AND IRON IN THE GENERATION OF ACTIVE OXYGEN RADICALS [J].
CLEJAN, L ;
CEDERBAUM, AI .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (11) :1779-1786
[9]   STABLE EXPRESSION OF HUMAN CYTOCHROME-P4502E1 IN HEPG2 CELLS - CHARACTERIZATION OF CATALYTIC ACTIVITIES AND PRODUCTION OF REACTIVE OXYGEN INTERMEDIATES [J].
DAI, Y ;
RASHBASTEP, J ;
CEDERBAUM, AI .
BIOCHEMISTRY, 1993, 32 (27) :6928-6937
[10]  
Dai Y, 1995, J PHARMACOL EXP THER, V275, P1614